METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm

Group 1 - A class action lawsuit has been filed against Metagenomi, Inc. in the United States District Court for the Northern District of California on behalf of investors who purchased Metagenomi securities during the initial public offering period from February 9, 2024, to May 1, 2024 [1] - The complaint alleges that Metagenomi made materially false and misleading statements and failed to disclose adverse facts about its business and operations [3] - The company presented itself as a "genetic medicines company" with a significant collaboration with Moderna, claiming a Strategic Collaboration and License Agreement established on October 29, 2021, which included multiple research programs [3]